Target Name: MARS1
NCBI ID: G4141
Review Report on MARS1 Target / Biomarker Content of Review Report on MARS1 Target / Biomarker
MARS1
Other Name(s): METRS | MARS | SYMC_HUMAN | SPG70 | Methionyl-tRNA synthetase, cytoplasmic | Methionyl-tRNA synthetase | Methionine translase | MetRS | methionyl-tRNA synthetase 1 | ILLD | cytosolic methionyl-tRNA synthetase | FLJ35667 | Methionyl-tRNA synthetase 1 | MTRNS | TTD9 | Methionyl-transfer ribonucleate synthetase | Methionine tRNA ligase 1, cytoplasmic | Methionyl-transfer ribonucleic acid synthetase | CMT2U | Methionyl-transfer RNA synthetase | Cytosolic methionyl-tRNA synthetase | MRS | ILFS2 | Methionine--tRNA ligase, cytoplasmic

MARS1: A Protein Kinase Involved in Cell Signaling and Energy Metabolism

MARS1, short for METRS-1, is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the METR family of proteins, which are involved in the regulation of mitochondrial function and energy metabolism.

One of the main functions of MARS1 is to act as a protein kinase, which means it can catalyze the transfer of a phosphate group from other proteins to itself. This process, known as protein phosphorylation, can modulate the activity and localization of MARS1 and its downstream targets.

MARS1 has been shown to play a role in a variety of physiological processes in the body, including cell signaling, metabolism, and stress response. For example, MARS1 has been shown to be involved in the regulation of mitochondrial function, which is critical for the production of energy by the cell.

MARS1 has also been shown to be involved in the regulation of cellular signaling pathways that are involved in cell growth, differentiation, and survival. For example, MARS1 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the production of signals that promote cell growth and survival.

In addition to its role in cellular signaling, MARS1 has also been shown to have potential as a drug target. Several studies have shown that inhibitors of MARS1 have been shown to have therapeutic effects in a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease.

One of the potential mechanisms by which MARS1 can be targeted with drugs is through its role in the regulation of mitochondrial function. By inhibiting the activity of MARS1, researchers can reduce the production of reactive oxygen species (ROS) in the mitochondria, which can damage the mitochondria and contribute to a variety of diseases.

Another potential mechanism by which MARS1 can be targeted with drugs is through its role in the regulation of cellular signaling pathways. For example, inhibitors of MARS1 have been shown to have therapeutic effects in diseases that are characterized by the overproduction of signaling molecules, such as neurodegenerative diseases.

In conclusion, MARS1 is a protein that is involved in a variety of physiological processes in the body, including cell signaling and energy metabolism. It is also a potential drug target due to its role in the regulation of mitochondrial function and cellular signaling pathways. Further research is needed to fully understand the mechanisms of MARS1 and its potential as a drug target.

Protein Name: Methionyl-tRNA Synthetase 1

Functions: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA (PubMed:11714285). Plays a role in the synthesis of ribosomal RNA in the nucleolus (PubMed:10791971)

The "MARS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MARS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MARS2 | MARVELD1 | MARVELD2 | MARVELD3 | MAS1 | MAS1L | MASP1 | MASP2 | MAST1 | MAST2 | MAST3 | MAST4 | MASTL | MAT1A | MAT2A | MAT2B | MATCAP1 | MATCAP2 | MATK | MATN1 | MATN1-AS1 | MATN2 | MATN3 | MATN4 | MATR3 | Matrix Metalloproteinase (MMP) | MAU2 | MAVS | MAX | MAZ | MB | MB21D2 | MBD1 | MBD2 | MBD2-MBD3 complex | MBD3 | MBD3L1 | MBD3L2 | MBD3L3 | MBD3L4 | MBD3L5 | MBD4 | MBD5 | MBD6 | MBIP | MBL1P | MBL2 | MBLAC1 | MBLAC2 | MBNL1 | MBNL1-AS1 | MBNL2 | MBNL3 | MBOAT1 | MBOAT2 | MBOAT4 | MBOAT7 | MBP | MBTD1 | MBTPS1 | MBTPS2 | MC1R | MC2R | MC3R | MC4R | MC5R | MCAM | MCAT | MCC | MCCC1 | MCCC2 | MCCD1 | MCCD1P1 | MCEE | MCEMP1 | MCF2 | MCF2L | MCF2L-AS1 | MCF2L2 | MCFD2 | MCFD2P1 | MCHR1 | MCHR2 | MCHR2-AS1 | MCIDAS | MCL1 | MCM10 | MCM2 | MCM3 | MCM3AP | MCM3AP-AS1 | MCM4 | MCM5 | MCM6 | MCM7 | MCM8 | MCM8-MCM9 complex | MCM9 | MCMBP | MCMDC2